HALOZYME THERAPEUTICS INC (HALO) Stock Fundamental Analysis
USA - NASDAQ:HALO - US40637H1095 - Common Stock
66.03 USD
-0.62 (-0.93%)
Taking everything into account, HALO scores 8 out of 10 in our fundamental rating. HALO was compared to 536 industry peers in the Biotechnology industry. HALO gets an excellent profitability rating and is at the same time showing great financial health properties. HALO is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, HALO could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year HALO was profitable.
In the past year HALO had a positive cash flow from operations.
HALO had positive earnings in each of the past 5 years.
In the past 5 years HALO always reported a positive cash flow from operatings.
1.2 Ratios
HALO has a Return On Assets of 27.13%. This is amongst the best in the industry. HALO outperforms 97.76% of its industry peers.
HALO has a better Return On Equity (167.48%) than 99.63% of its industry peers.
With an excellent Return On Invested Capital value of 28.55%, HALO belongs to the best of the industry, outperforming 98.88% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HALO is above the industry average of 15.49%.
The last Return On Invested Capital (28.55%) for HALO is above the 3 year average (17.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 27.13% | ||
| ROE | 167.48% | ||
| ROIC | 28.55% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
1.3 Margins
Looking at the Profit Margin, with a value of 47.28%, HALO belongs to the top of the industry, outperforming 98.88% of the companies in the same industry.
HALO's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 57.92%, HALO belongs to the top of the industry, outperforming 99.81% of the companies in the same industry.
HALO's Operating Margin has declined in the last couple of years.
HALO has a Gross Margin of 84.20%. This is amongst the best in the industry. HALO outperforms 87.13% of its industry peers.
HALO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 57.92% | ||
| PM (TTM) | 47.28% | ||
| GM | 84.2% |
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HALO is creating value.
HALO has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HALO has been reduced compared to 5 years ago.
Compared to 1 year ago, HALO has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.21 indicates that HALO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.21, HALO is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
HALO has a debt to FCF ratio of 2.79. This is a good value and a sign of high solvency as HALO would need 2.79 years to pay back of all of its debts.
The Debt to FCF ratio of HALO (2.79) is better than 94.03% of its industry peers.
A Debt/Equity ratio of 4.54 is on the high side and indicates that HALO has dependencies on debt financing.
The Debt to Equity ratio of HALO (4.54) is worse than 81.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.54 | ||
| Debt/FCF | 2.79 | ||
| Altman-Z | 5.21 |
ROIC/WACC3.3
WACC8.65%
2.3 Liquidity
A Current Ratio of 8.36 indicates that HALO has no problem at all paying its short term obligations.
HALO has a Current ratio of 8.36. This is in the better half of the industry: HALO outperforms 74.44% of its industry peers.
HALO has a Quick Ratio of 7.01. This indicates that HALO is financially healthy and has no problem in meeting its short term obligations.
HALO's Quick ratio of 7.01 is fine compared to the rest of the industry. HALO outperforms 69.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.36 | ||
| Quick Ratio | 7.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 58.41% over the past year.
Measured over the past years, HALO shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.12% on average per year.
HALO shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.97%.
HALO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.95% yearly.
EPS 1Y (TTM)58.41%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%69.23%
Revenue 1Y (TTM)34.97%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%40.79%
3.2 Future
The Earnings Per Share is expected to grow by 18.27% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.85% on average over the next years. This is quite good.
EPS Next Y48.66%
EPS Next 2Y38.6%
EPS Next 3Y33.13%
EPS Next 5Y18.27%
Revenue Next Year31.57%
Revenue Next 2Y27.61%
Revenue Next 3Y24.03%
Revenue Next 5Y13.85%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.75, HALO is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 96.83% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.49, HALO is valued rather cheaply.
HALO is valuated reasonably with a Price/Forward Earnings ratio of 8.13.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 98.13% of the companies listed in the same industry.
HALO is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.75 | ||
| Fwd PE | 8.13 |
4.2 Price Multiples
96.27% of the companies in the same industry are more expensive than HALO, based on the Enterprise Value to EBITDA ratio.
HALO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HALO is cheaper than 96.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.28 | ||
| EV/EBITDA | 10.82 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of HALO may justify a higher PE ratio.
A more expensive valuation may be justified as HALO's earnings are expected to grow with 33.13% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y38.6%
EPS Next 3Y33.13%
5. Dividend
5.1 Amount
No dividends for HALO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:HALO (10/15/2025, 2:45:07 PM)
66.03
-0.62 (-0.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners102.63%
Inst Owner Change-0.04%
Ins Owners0.85%
Ins Owner Change0.1%
Market Cap7.72B
Analysts75
Price Target76.12 (15.28%)
Short Float %10.19%
Short Ratio5.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.03%
Min EPS beat(2)14.79%
Max EPS beat(2)19.26%
EPS beat(4)4
Avg EPS beat(4)16.87%
Min EPS beat(4)6.64%
Max EPS beat(4)26.79%
EPS beat(8)7
Avg EPS beat(8)12.25%
EPS beat(12)10
Avg EPS beat(12)12.69%
EPS beat(16)13
Avg EPS beat(16)10.59%
Revenue beat(2)2
Avg Revenue beat(2)12.25%
Min Revenue beat(2)11.69%
Max Revenue beat(2)12.81%
Revenue beat(4)4
Avg Revenue beat(4)9.78%
Min Revenue beat(4)1.36%
Max Revenue beat(4)13.28%
Revenue beat(8)5
Avg Revenue beat(8)5.19%
Revenue beat(12)7
Avg Revenue beat(12)3.36%
Revenue beat(16)9
Avg Revenue beat(16)2.8%
PT rev (1m)4.37%
PT rev (3m)5.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.57%
EPS NY rev (1m)0.47%
EPS NY rev (3m)12.09%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)2.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.75 | ||
| Fwd PE | 8.13 | ||
| P/S | 6.55 | ||
| P/FCF | 14.28 | ||
| P/OCF | 14.1 | ||
| P/B | 23.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.82 |
EPS(TTM)5.18
EY7.84%
EPS(NY)8.13
Fwd EY12.31%
FCF(TTM)4.62
FCFY7%
OCF(TTM)4.68
OCFY7.09%
SpS10.08
BVpS2.84
TBVpS-3.85
PEG (NY)0.26
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 27.13% | ||
| ROE | 167.48% | ||
| ROCE | 35.56% | ||
| ROIC | 28.55% | ||
| ROICexc | 39.96% | ||
| ROICexgc | 93.15% | ||
| OM | 57.92% | ||
| PM (TTM) | 47.28% | ||
| GM | 84.2% | ||
| FCFM | 45.87% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
ROICexc(3y)23.94%
ROICexc(5y)N/A
ROICexgc(3y)71.73%
ROICexgc(5y)N/A
ROCE(3y)22.19%
ROCE(5y)37.11%
ROICexcg growth 3Y-1.13%
ROICexcg growth 5YN/A
ROICexc growth 3Y-28.16%
ROICexc growth 5YN/A
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
F-Score8
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.54 | ||
| Debt/FCF | 2.79 | ||
| Debt/EBITDA | 1.97 | ||
| Cap/Depr | 8.67% | ||
| Cap/Sales | 0.6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.66% | ||
| Profit Quality | 97.02% | ||
| Current Ratio | 8.36 | ||
| Quick Ratio | 7.01 | ||
| Altman-Z | 5.21 |
F-Score8
WACC8.65%
ROIC/WACC3.3
Cap/Depr(3y)13.62%
Cap/Depr(5y)33.32%
Cap/Sales(3y)1.21%
Cap/Sales(5y)0.98%
Profit Quality(3y)118.15%
Profit Quality(5y)93.9%
High Growth Momentum
Growth
EPS 1Y (TTM)58.41%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%69.23%
EPS Next Y48.66%
EPS Next 2Y38.6%
EPS Next 3Y33.13%
EPS Next 5Y18.27%
Revenue 1Y (TTM)34.97%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%40.79%
Revenue Next Year31.57%
Revenue Next 2Y27.61%
Revenue Next 3Y24.03%
Revenue Next 5Y13.85%
EBIT growth 1Y68.72%
EBIT growth 3Y25.97%
EBIT growth 5YN/A
EBIT Next Year61.62%
EBIT Next 3Y39.07%
EBIT Next 5Y15.57%
FCF growth 1Y84.66%
FCF growth 3Y16.28%
FCF growth 5YN/A
OCF growth 1Y79.07%
OCF growth 3Y16.96%
OCF growth 5YN/A